Literature DB >> 28513464

Pharmacological features of osthole.

Agata Jarząb1, Aneta Grabarska1, Krystyna Skalicka-Woźniak2, Andrzej Stepulak1.   

Abstract

Coumarins are a group of naturally occurring compounds common in the plant world. These substances and their derivatives exhibit a broad range of biological activities. One of the naturally occurring coumarins is osthole, which can most frequently be found in plants of the Apiaceae family. Cnidium monnieri (L.) Cusson ex Juss. Angelica pubescens Maxim. and Peucedanum ostruthium (L.). It has anti-proliferative, anti-inflammatory, anti-convulsant, and antiallergic properties; apart from that, inhibition of platelet aggregation has also been proved. The impact of osthole on bone metabolism has been demonstrated; also its hepatoprotective and neuroprotective properties have been confirmed. The inhibitory effect of this metokcompound on the development of neurodegenerative diseases has been proved in experimental models. Anticancer features of osthole have been also demonstrated both in vitro on different cell lines, and in vivo using animals xenografts. Osthole inhibited proliferation, motility and invasiveness of tumor cells, which may be associated with the induction of apoptosis and cell cycle slowdown. The exact molecular mechanism of osthole anti-cancer mode of action has not been fully elucidated. A synergistic effect of osthole with other anti-tumor substances has been also reported. Modification of its chemical structure led to the synthesis of many derivatives with significant anticancer effects. To sum up, osthole is an interesting therapeutic option, due to both its direct effect on tumor cells, as well as its neuroprotective or anti-inflammatory properties. Thus, there is a chance to use osthole or its synthetic derivatives in the treatment of cancer.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28513464     DOI: 10.5604/01.3001.0010.3824

Source DB:  PubMed          Journal:  Postepy Hig Med Dosw (Online)        ISSN: 0032-5449            Impact factor:   0.270


  7 in total

1.  Effect of combined treatment with lobaplatin and osthole on inducing apoptosis and inhibiting proliferation in human breast cancer MDA-MB-231 cells.

Authors:  Nan Liu; Hao Tian; Guoduo Zhang; Na Sun; Shumei Wang
Journal:  Med Oncol       Date:  2021-11-27       Impact factor: 3.064

2.  Computational Screening of the Natural Product Osthole and Its Derivates for Anti-Inflammatory Activity.

Authors:  Angela Mosebarger; Rambabu N Reddi; Ramkumar Menon; Ananth Kumar Kammala
Journal:  Life (Basel)       Date:  2022-03-30

3.  Osthole Protects against Acute Lung Injury by Suppressing NF-κB-Dependent Inflammation.

Authors:  Yiyi Jin; Jianchang Qian; Xin Ju; Xiaodong Bao; Li Li; Suqing Zheng; Xiong Chen; Zhongxiang Xiao; Xuemei Chen; Weiwei Zhu; Weixin Li; Wencan Wu; Guang Liang
Journal:  Mediators Inflamm       Date:  2018-07-03       Impact factor: 4.711

4.  Do Different Species of Sargassum in Haizao Yuhu Decoction Cause Different Effects in a Rat Goiter Model?

Authors:  Dianna Liu; Feng Chen; Xue Yu; Linlin Xiu; Haiyan Liu; Shaohong Chen; Jie Gao; Chen Zhang; Na Li; Cheng He; Gansheng Zhong
Journal:  Evid Based Complement Alternat Med       Date:  2019-01-06       Impact factor: 2.629

5.  The Role of Osthole on TGF-β-Induced Lung Epithelium Apoptosis Injury and Epithelial-Mesenchymal Transition-Mediated Airway Remodeling in Pediatric Asthma.

Authors:  Jinghai Tang; Jilong Liu; Xuehua Zhang
Journal:  J Healthc Eng       Date:  2022-03-24       Impact factor: 2.682

Review 6.  Osthole: An up-to-date review of its anticancer potential and mechanisms of action.

Authors:  Shaojie Yang; Wanlin Dai; Jingnan Wang; Xiaolin Zhang; Yuting Zheng; Shiyuan Bi; Liwei Pang; Tengqi Ren; Ye Yang; Yang Sun; Zhuyuan Zheng; Shuodong Wu; Jing Kong
Journal:  Front Pharmacol       Date:  2022-09-07       Impact factor: 5.988

Review 7.  Coumarins as Modulators of the Keap1/Nrf2/ARE Signaling Pathway.

Authors:  Emad H M Hassanein; Ahmed M Sayed; Omnia E Hussein; Ayman M Mahmoud
Journal:  Oxid Med Cell Longev       Date:  2020-04-22       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.